Cleo Diagnostics Ltd has released a press release.
Appendix 4E and 2025 Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from CLEO Diagnostics
- COV Commences Health Economic Study-Support US Market Entry
- CLEO Strengthens FDA Submission - Access to US Biobank
- Corporate Presentation
- Cleo Advances with Completion of Alpha Testing
- CLEO to Fast Track Development of Ovarian Cancer Test
Later from CLEO Diagnostics
- Cleo Receives Positive FDA Feedback
- CLEO Successfully Completes Stage 1 MDSAP Audit
- CLEO Significantly Expands Addressable Market
- CLEO Appoints First Key Opinion Leader to Support US Market
- Cleo Strengthens Cash Position with $1.7m R&D Tax Refund
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics